A former farm worker named Enrique Rubio may just be the right “David” to take down “Goliath” chemical company Monsanto. Rubio filed suit against the manufacturer of Roundup® early last week, claiming that the company’s infamous herbicide is the cause of his bone cancer and inability to work.
Roundup’s® safety has been hotly debated for
Recently, Reuters reported that “Drug companies generally don’t disclose all the reasons new medicines fail to win U.S. marketing approval, even though regulators often reject treatments over concerns about safety or effectiveness”.
Reporter Lisa Rapaport quotes Dr. Peter Lurie, FDA associate commissioner for public health strategy and analysis, saying “‘Only a minority of the press
Recently, a craniofacial distraction implant by DePuy Orthopaedics was recalled. This device, called the Craniomaxillofacial (CMF) Distraction System, “is a modular family of internal distraction devices that are used to gradually lengthen the mandible body and ramus” and indicated as “a bone stabilizer and lengthening (and/or transport) device for correction of congenital deficiencies
A man by the name of Sandeep Barot has filed a proposed consumer protection class-action lawsuit against the manufacturer and distributor of dietary supplements that allegedly cause liver damage. See Barot v. USPLabs LLC et al., No. 1:14-cv-00562, complaint filed (D.N.J. Feb. 3, 2014).
The defendant companies are USPLabs, LLC (“USPLabs”) and General Nutrition
Though the diet supplement OxyElite Pro was recalled last year due to a connection with liver damage and acute liver failure, more people continue to get sick, according to a recent report by Scientific American.
Currently, at least 97 people have suffered severe hepatitis in connection with OxyElite Pro, and one person has died.
In the wake of the recent fungal meningitis outbreak that left 64 dead and infected some 751 Americans, traced back contaminated steroid injections from the New England Compounding Center (Framingham, MA), the United States Food and Drug Administration has sought greater oversight over the pharmacy compounding industry.
To that end, Congress passed the Drug
Yesterday (1/16/2014) Reuters reported that an FDA advisory panel rejected a call by Johnson and Johnson to approve their anticoagulant Xarelto (rivaroxaban) for acute coronary syndrome by a vote of 10-0 with one abstention.
While Xarelto “is already used to treat and prevent deep vein thrombosis and pulmonary embolisms and to reduce the
Recent reports from MarketWatch and Bloomberg Businessweek cite that the US drug prices fell by about 1% last month, representing the largest such dip in prices in decades.
Interestingly, MarketWatch reported that the cost of drugs fell by 0.9%, and that this was the biggest monthly drop since 1969, and Bloomberg reported the cost fell
A press release today from the US Department of Health and Human Services touts a new regulation “strengthens community living options for for older Americans and people with disabilities”.
This comes as the Centers for Medicare and Medicaid Services (CMS) “issued a final rule today to ensure that Medicaid’s home and community-based services
On Thursday, January 9th 2014, MedlinePlus reported that gene therapy may be helpful to patients suffering from advanced-stage Parkinson’s disease, as demonstrated by new research.
According to the researchers, this therapy, “called ProSavin, works by reprogramming brain cells to produce dopamine, the chemical essential for controlling movement”. (MedlinePlus)
This research comes from